je.st
news
Home
› Nodality Inc. Presents Data From Immuno-Oncology Program Applying Company's Novel Single Cell Network Profiling (SCNP) Platform
Nodality Inc. Presents Data From Immuno-Oncology Program Applying Company's Novel Single Cell Network Profiling (SCNP) Platform
2015-02-27 01:59:32| drugdiscoveryonline Home Page
Nodality, Inc., which is focused on solving drug development challenges, recently announced research results from its lead immuno-oncology efforts based on applications of the Company’s Single Cell Network Profiling (SCNP) technology
Tags: data
program
single
network
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||